V. Cangemi et al., RESULTS OF SURGICAL-TREATMENT OF STAGE IIIA NONSMALL CELL LUNG-CANCER, European journal of cardio-thoracic surgery, 9(7), 1995, pp. 352-359
From 1975 to 1993, 665 patients with non-small cell lung carcinoma (NS
CLC) were studied in our Unit. Of the 55 stage IIIA patients submitted
to resection, 50 were followed-up in order to evaluate the effectiven
ess of surgery and to identify which variables had a prognostic impact
on survival. The expectancy of survival at 3,5 and 10 years was 31.7,
19.5 and 13.7%, respectively. When the analysis was limited to N2 pat
ients, 3,5- and 10-year survival rates were 20.9, 14 and 7%, resepctiv
ely. Regarding the ''TN'' factor, the T3NO subset presented the highes
t expected survival (24.8 and 18.6% at 5 and 10 years). With regard to
the ''T3'' factor and type of surgery, peripheral tumors submitted to
en bloc resection of the chest wall showed the best 5-year survival r
ate (42.9%), whereas extrapleural resections - even for tumors confine
d to the parietal pleura - showed a 5-year survival rate of 14.3%. A s
lightly higher risk of death was observed in tumors originating in the
superior sulcus (SST). No patients with mediastinal pleura and perica
rdium involvement survived more than 34 months. With univariate analys
is, ''N2'' was the variable most significantly associated with a negat
ive prognosis when related to T3 (T3N2 vs T3NO 0.025<P<0.05) or non-ep
idermoid tumor (no survivors at 3 years; N2 epidermoid vs N2 non-epide
rmoid tumor P<0.05). Applying multivariate analysis, epidermoid cell t
ype, even if exclusively for N2 tumors, was an independent prognostic
factor, showing a favorable impact on survival expectancy (27.8% at 90
months).